Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores
717.00 €
In Stock
quantity
product details
Catalog number: 1028 - NCT861
Product Category: Business & Industrial > Science & Laboratory
Gentaur
Size: row: 9; column: 10; cores: 86; cases: 43
NCT861
Brain metastatic carcinoma tissue array, including pathology grade, 43 cases/86 cores
Brain metastatic carcinoma tissue microarray, containing 43 cases metastatic carcinoma, duplicate core per case
717.00 €
NCT1921
Brain tumor tissue array, including pathology grade, 96 cases/192 cores
Brain tumor tissue microarray,containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 malignant ependymocytoma, 2 each of malignant ganglioglioma and glioma sarcomatosum, 1 medulloblastoma), 28 cases in mid stage, 68 in advanced stage, duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening.
861.00 €
NCT1921a
Brain tumor tissue array, including pathology grade, 96 cases/192 cores
Brain tumor tissue microarray, containing 96 cases of tumor (47 astrocytoma, 41 glioblastoma, 3 ependymoma, 2 each of ganglion glioma and gliosarcoma, 1 medulloblastoma), duplicate cores per case, divided into two identical 96 core arrays, suitable for therapeutic antibody screening.
1041.00 €
BR484b
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR484a
Breat invasivecarcinoma of no special type tissue microarray, containing 48 cases of breast invasive carcinoma of no special type, single core per case
609.00 €
BR728
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing BC08015
Breast carcinoma tissue microarray, containing 9 cases of invasive carcinoma of no special type, 3 invasive lobular carcinoma, 2 medullary carcinoma, 1 papillary carcinoma, 3 intraductal carcinoma and 3 paget's disease, triplicate cores per case
555.00 €
BR965
Breast cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores, replacing BRC962
Breast carcinoma tissue microarray, containing 23 cases of breast invasive ductal carcinoma, 1 each of breast invasive cribriform carcinoma, breast mucinous carcinoma, breast squamous cell carcinoma, breast carcinoma in situ and breast cystosarcoma phyllodes, 4 each of breast invasive papillary carcinoma and breast fibroadenoma, 2 each of breast invasive lobular carcinoma, breast apocrine carcinoma, breast adenosis and breast granulomatous inflammation, 3 breast hyperplasia, plus 1 normal breast tissue, duplicate cores per case (duplicated cores from the same patient were put onto upper and lower rows in the same position)